Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1571826

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1571826

Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microscopy, Rapid Diagnostic Tests), By End Use (Clinics, Hospitals), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 125 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Malaria Diagnostics Market Growth & Trends:

The global malaria diagnostics market size is projected to reach USD 900.5 million by 2030, expanding at a CAGR of 2.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of the tropical disease in endemic countries, development of novel diagnostic techniques, and rising investments by regional governments and private investors are expected to propel market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to changing climate, low economic growth, underdeveloped healthcare infrastructure, and lack of access to advanced treatment.

Increasing number of government initiatives and investments by market participants are also anticipated to fuel market growth in the near future. Use of antimalarial treatments options that were abundantly available in the African region were used for the management and control of spread during the COVID-19 pandemic. The market noticed a significant boost during the COVID-19 outbreak owing to the ever-increasing malaria cases in addition to the COVID-19 virus.

A large number of malarial elimination programs are being undertaken by major companies to reduce the disease prevalence. For instance, Novartis's Malaria Initiative was aimed at facilitating malaria elimination and control. Along with various organizations, the company has provided non-profit treatment to 750 million people across 60 countries. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market penetration.

Malaria Diagnostics Market Report Highlights:

  • Conventional usage of microscopic examination for detection of malarial parasite has driven the microscopy technology segment
  • RDTs are anticipated to account for the largest revenue share owing to ease of usage, convenience, and rapid diagnosis.
  • The molecular diagnostic tests segment is projected to be the fastest-growing technology segment during the forecast period owing to their accuracy and capability of detecting low parasite count.
  • Africa led the market in 2023 due to high disease incidence and increased adoption of various malarial diagnostic techniques in the region.
  • Southeast Asia is expected to grow at a CAGR of 2.3% owing to high disease reoccurrence and initiatives undertaken to curb malarial incidence.
Show more
Product Code: 978-1-68038-711-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Malaria Diagnostics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing demand for diagnostic tools in malaria-endemic countries
      • 3.2.1.2. Development of technologically advanced and efficient diagnostics
      • 3.2.1.3. Market players and private investors to curb the prevalence of malaria
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Increasing number of countries in the malaria elimination phase
      • 3.2.2.2. Demand for low-cost malaria diagnostic tests
  • 3.3. Malaria Diagnostics Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Malaria Diagnostics Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Malaria Diagnostics Market by Technology Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Molecular Diagnostic Tests
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.2. Conventional PCR
        • 4.4.1.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
      • 4.4.1.3. Modernized PCR
        • 4.4.1.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Microscopy
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Rapid Diagnostic Tests (RDT)

Chapter 5. Malaria Diagnostics Market: End Use Estimates & Trend Analysis

  • 5.1. Method Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Malaria Diagnostics Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals & Clinics
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
    • 5.4.2. Diagnostic Centers
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Academic and Research Institutes
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Malaria Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.5. Africa
    • 6.5.1. Nigeria
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Nigeria market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Democratic Republic of the Congo
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Democratic Republic of the Congo market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. United Republic of Tanzania
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. United Republic of Tanzania market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Uganda
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Uganda market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Africa
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Mozambique
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Mozambique market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.7. Angola
      • 6.5.7.1. Key country dynamics
      • 6.5.7.2. Regulatory framework/ reimbursement structure
      • 6.5.7.3. Competitive scenario
      • 6.5.7.4. Angola market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.8. Ghana
      • 6.5.8.1. Key country dynamics
      • 6.5.8.2. Regulatory framework/ reimbursement structure
      • 6.5.8.3. Competitive scenario
      • 6.5.8.4. Ghana market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.9. Botswana
      • 6.5.9.1. Key country dynamics
      • 6.5.9.2. Regulatory framework/ reimbursement structure
      • 6.5.9.3. Competitive scenario
      • 6.5.9.4. Botswana market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.10. Namibia
      • 6.5.10.1. Key country dynamics
      • 6.5.10.2. Regulatory framework/ reimbursement structure
      • 6.5.10.3. Competitive scenario
      • 6.5.10.4. Namibia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. South East Asia
    • 6.6.1. India
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Myanmar
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Myanmar market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. Indonesia
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. Indonesia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Eastern Mediterranean
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Pakistan
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Pakistan market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.8. Western Pacific
    • 6.8.1. China
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.2. Papua New Guinea
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Papua New Guinea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.8.3. Cambodia
      • 6.8.3.1. Key country dynamics
      • 6.8.3.2. Regulatory framework/ reimbursement structure
      • 6.8.3.3. Competitive scenario
      • 6.8.3.4. Cambodia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.9. Americas
    • 6.9.1. Venezuela
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. Venezuela market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.2. Brazil
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.9.3. Colombia
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. Colombia market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.10. Europe
    • 6.10.1. UK
      • 6.10.1.1. Key country dynamics
      • 6.10.1.2. Regulatory framework/ reimbursement structure
      • 6.10.1.3. Competitive scenario
      • 6.10.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.2. Germany
      • 6.10.2.1. Key country dynamics
      • 6.10.2.2. Regulatory framework/ reimbursement structure
      • 6.10.2.3. Competitive scenario
      • 6.10.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.3. France
      • 6.10.3.1. Key country dynamics
      • 6.10.3.2. Regulatory framework/ reimbursement structure
      • 6.10.3.3. Competitive scenario
      • 6.10.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.10.4. Turkey
      • 6.10.4.1. Key country dynamics
      • 6.10.4.2. Regulatory framework/ reimbursement structure
      • 6.10.4.3. Competitive scenario
      • 6.10.4.4. Turkey market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Access Bio, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Abbott Laboratories
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Premier Medical Corporation Pvt. Ltd.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Sysmex Partec GmbH
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Siemens Healthineers
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. bioMerieux
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Beckman Coulter, Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Leica Microsystems GmbH
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Bio-Rad Laboratories, Inc.
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
Show more
Product Code: 978-1-68038-711-7

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 Africa malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 3 Africa malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 4 Africa malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Nigeria malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 6 Nigeria malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Democratic Republic of Congo malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 8 Democratic Republic of Congo malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Uganda malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 10 Uganda malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 11 United Republic of Tanzania malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 12 United Republic of Tanzania malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 13 South Africa malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 14 South Africa malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Mozambique malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 16 Mozambique malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Angola malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Angola malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Ghana malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Ghana malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Botswana malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Botswana malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Namibia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Namibia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 25 South East Asia malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 26 South East Asia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 27 South East Asia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 28 India malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 29 India malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Myanmar malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 31 Myanmar malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Indonesia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Indonesia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Eastern Mediterranean malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 35 Eastern Mediterranean malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Eastern Mediterranean malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Saudi Arabia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 38 Saudi Arabia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 39 Pakistan malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 40 Pakistan malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Western Pacific malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 42 Western Pacific malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Western Pacific malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 44 China malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 45 China malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Papua New Guinea malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 47 Papua New Guinea malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Cambodia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Cambodia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Americas malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 51 Americas malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 52 Americas malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Venezuela malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 54 Venezuela malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Brazil malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 56 Brazil malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 57 Colombia malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Colombia malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Europe malaria diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 60 Europe malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Europe malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Turkey malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 63 Turkey malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 64 France malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 65 France malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 66 UK malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 67 UK malaria diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Germany malaria diagnostics market, by technology, 2018 - 2030 (USD Million)
  • Table 69 Germany malaria diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in Africa
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in South East Asia
  • Fig. 7 Primary interviews in Eastern Mediterranean
  • Fig. 8 Primary interviews in Western Pacific
  • Fig. 9 Primary interviews in Americas
  • Fig. 10 Primary interviews in Europe
  • Fig. 11 Market research approaches
  • Fig. 12 Value-chain-based sizing & forecasting
  • Fig. 13 QFD modeling for market share assessment
  • Fig. 14 Market formulation & validation
  • Fig. 15 Malaria Diagnostics market: market outlook
  • Fig. 16 Malaria Diagnostics competitive insights
  • Fig. 17 Parent market outlook
  • Fig. 18 Related/ancillary market outlook
  • Fig. 19 Penetration and growth prospect mapping
  • Fig. 20 Industry value chain analysis
  • Fig. 21 Malaria Diagnostics market driver impact
  • Fig. 22 Malaria Diagnostics market restraint impact
  • Fig. 23 Malaria Diagnostics market strategic initiatives analysis
  • Fig. 24 Malaria Diagnostics market: Technology movement analysis
  • Fig. 25 Malaria Diagnostics market: Technology outlook and key takeaways
  • Fig. 26 Molecular Diagnostic Tests market estimates and forecasts, 2018 - 2030
  • Fig. 27 Conventional PCR market estimates and forecasts, 2018 - 2030
  • Fig. 28 Modernized PCR market estimates and forecasts, 2018 - 2030
  • Fig. 29 Microscopy market estimates and forecasts, 2018 - 2030
  • Fig. 30 Rapid Diagnostic Tests (RDT) market estimates and forecasts, 2018 - 2030
  • Fig. 31 Malaria Diagnostics market: End Use movement analysis
  • Fig. 32 Malaria Diagnostics market: End Use outlook and key takeaways
  • Fig. 33 Hospitals & Clinics market estimates and forecasts, 2018 - 2030
  • Fig. 34 Diagnostic Centers market estimates and forecasts, 2018 - 2030
  • Fig. 35 Academic and Research Institutes market estimates and forecasts, 2018 - 2030
  • Fig. 36 Global malaria diagnostics market: Regional movement analysis
  • Fig. 37 Global malaria diagnostics market: Regional outlook and key takeaways
  • Fig. 38 Global malaria diagnostics market share and leading players
  • Fig. 39 Africa market share and leading players
  • Fig. 40 Europe market share and leading players
  • Fig. 41 South East Asia market share and leading players
  • Fig. 42 Eastern Mediterranean market share and leading players
  • Fig. 43 Western Pacific market share and leading players
  • Fig. 44 Americas market share and leading players
  • Fig. 45 Africa market estimates and forecasts, 2018 - 2030
  • Fig. 46 Nigeria market estimates and forecasts, 2018 - 2030
  • Fig. 47 Democratic Republic of Congo market estimates and forecasts, 2018 - 2030
  • Fig. 48 Uganda market estimates and forecasts, 2018 - 2030
  • Fig. 49 United Republic of Tanzania market estimates and forecasts, 2018 - 2030
  • Fig. 50 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 51 Mozambique market estimates and forecasts, 2018 - 2030
  • Fig. 52 Angola market estimates and forecasts, 2018 - 2030
  • Fig. 53 Ghana market estimates and forecasts, 2018 - 2030
  • Fig. 54 Botswana market estimates and forecasts, 2018 - 2030
  • Fig. 55 Namibia market estimates and forecasts, 2018 - 2030
  • Fig. 56 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 59 France market estimates and forecasts, 2018 - 2030
  • Fig. 60 Turkey market estimates and forecasts, 2018 - 2030
  • Fig. 61 South East Asia market estimates and forecasts, 2018 - 2030
  • Fig. 62 India market estimates and forecasts, 2018 - 2030
  • Fig. 63 Myanmar market estimates and forecasts, 2018 - 2030
  • Fig. 64 Indonesia market estimates and forecasts, 2018 - 2030
  • Fig. 65 Eastern Mediterranean market estimates and forecasts, 2018 - 2030
  • Fig. 66 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 67 Pakistan market estimates and forecasts, 2018 - 2030
  • Fig. 68 Western Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 69 China market estimates and forecasts, 2018 - 2030
  • Fig. 70 Papua New Guinea market estimates and forecasts, 2018 - 2030
  • Fig. 71 Cambodia market estimates and forecasts, 2018 - 2030
  • Fig. 72 Americas market estimates and forecasts, 2018 - 2030
  • Fig. 73 Venezuela market estimates and forecasts, 2018 - 2030
  • Fig. 74 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 75 Colombia market estimates and forecasts, 2018 - 2030
  • Fig. 76 Market share of key market players- Malaria Diagnostics market
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!